Top Story

George C. Tsokos, MD, selected to receive 2015 Lupus Insight Prize

May 22, 2015

The Alliance for Lupus Research, the Lupus Foundation of America and the Lupus Research Institute have announced George C. Tsokos, MD, chief of the rheumatology division at Beth Israel Deaconess Medical Center and professor of medicine at Harvard Medical School, has been selected to receive the third-annual Lupus Insight Prize.

Tsokos plans to use the $200,000 award to study the molecular link between the immune systems and kidney damage related to lupus nephritis, according to a press release. Earlier work by Tsokos and colleagues demonstrated the enzyme calcium calmodulin kinase 4 (CaMK4) may be involved in inflammation in lupus, and Tsokos hopes to develop targeted delivery of drugs to block the action of the enzyme.

In the Journals

Thiopurine S-methyltransferase levels may predict azathioprine toxicity in Behçet’s disease

May 22, 2015
Low levels of thiopurine S-methyltransferase may be predictive of adverse events caused by azathioprine toxicity in patients with Behçet’s disease, according to…

Sarilumab meets primary endpoint in phase 3 rheumatoid arthritis trial

May 22, 2015
Regeneron Pharmaceuticals and Sanofi have announced sarilumab met its primary endpoints after 24 weeks in a phase 3 trial of patients with rheumatoid arthritis…
In the Journals

No differences in early mortality between simultaneous and staged bilateral surgery

May 22, 2015
Results of a recently published study showed there were no clinically relevant differences in early postoperative mortality among healthy patients who underwent…
In the Journals

Lower BMI linked to better response to infliximab in patients with RA

May 21, 2015
Patients with rheumatoid arthritis and lower BMI showed a better response to treatment with infliximab compared with patients with a higher BMI, according to study…
More News Headlines »
CME
Rheumatology Case Consults

Monitoring the Patient with Rheumatoid Arthritis for Disease Progression

No commercial support for this activity.

This CME activity will focus on monitoring the patient on treatment for rheumatoid arthritis for progression of…
More »
Meeting News Coverage Video
Study DSM 5 could not be properly applied to fibromyalgia patients th

Study: DSM-5 could not be properly applied to fibromyalgia patients

November 13, 2013
SAN DIEGO — Frederick Wolfe, MD, of the National Data Bank for Rheumatic Diseases, Wichita, Kan., presented…
More »
CME
Chronic OA Management: Volume 3, Number 3

Chronic OA Management: Volume 3, Number 3

This activity is supported by an educational grant from sanofi-aventis U.S.

Osteoarthritis (OA) is a chronic, progressive and multifactorial disease characterized by degenerative and inflammatory…
More »
morganatic-roan